Industry News
Latest orthopaedic industry news on orthopaedic companies, devices, implants & technology trends.
- Written by Editor-in-Chief
- Category: Industry News
Here are three highlights: 1. The global orthopedic devices market is anticipated to reach $47.5 billion by 2022. 2. Smaller companies introducing novel products are driving market growth. 3. To remain competitive in the space, manufacturers must offer devices with more advanced technology. More articles on devices: Flexion Therapeutics submits new drug application for knee osteoarthritis pain pill: 4 key notes Global hip, knee implant market to hit $33B by 2022: 5 observations SeaSpine names William Rhoda to new executive position: 5 things to know
- Written by Editor-in-Chief
- Category: Industry News
Image created by RRY Publications, LLC Lewallen v. Hofmann: The Cemented All-Poly Tibia: An Affordable Care Act Solution OTW Staff • Mon, December 12th, 2016 This week’s Orthopaedic Crossfire® debate was part of the 32nd Annual Current Concepts in Joint Replacement® (CCJR), Winter meeting, which took place in Orlando this past December. This week’s topic is The Cemented All-Poly Tibia: An Affordable Care Act Solution.” For the proposition is David G. Lewallen, M.D., Mayo Clinic, Rochester, Minnesota. Opposing is Aaron A. Hofmann, M.D.
- Written by mwood@beckershealthcare.com (Megan Wood)
- Category: Industry News
Here are five observations: 1. In 2015, 325,000 people underwent total hip replacement surgery in the Untied States. 2. Computer assistance represents a new trend in the total hip replacement surgery field. 3. The increasing aging population is driving the market. 4. Warsaw, Ind.-based Zimmer Biomet leads the hip and knee orthopedic implant market, offering its ML taper hip prosthesis with Kinectiv modular neck technology. 5. Other market leaders include: • DePuy Synthes in West Chester, Pa.
- Written by mwood@beckershealthcare.com (Megan Wood)
- Category: Industry News
Here are five insights: 1. Of the seven firms covering the company's stock, three rated it as "sell," three gave it a "hold" and three offered a "buy" rating. 2. Analysts gave Mazor Robotics an average 12-month price target of $27.67. 3. Mazor Robotics possesses a 50-day moving average of $22.68 and a 200-day moving average of $20.80. 4. The company's market capitalization is $529.2 million. 5. With a one-year low of $8.31, the company has a one-year high of $26.55.
- Written by mwood@beckershealthcare.com (Megan Wood)
- Category: Industry News
Here are four takeaways: 1. Initia features Kyocera Medical's BIOCERAM AZU zirconia-toughened alumina ceramic femoral heads. 2. Surgeons may also purchase the system with cobalt chrome femoral heads, which are matched to cross-linked polyethylene acetabular liners. 3. The system is available in 16 taper-wedge stem sizes, with 12 of those available in the United States. 4. Kyocera Medical manufactures implantable systems and advanced ceramic components. More articles on devices: Aurora Spine, Zimmer Biomet, DePuy Synthes & more: 11 key notes
- Written by mwood@beckershealthcare.com (Megan Wood)
- Category: Industry News
Here are five highlights: 1. The HoloLens guides surgeons to more accurately place pedicle screws. 2. The device is also intended to help surgeons avoid complications, like neural damage or implant loosening, by providing proper pedicle screw placement. 3. The HoloLens offers a 3-D CT scan, which provides a trajectory for screw placement. 4. Dr. Henrique Lampert and Dr. Bruno Gobbato, of the Instituto de Ortopedia e Traumatologia de Jaraguá do Su, have used the device.
- Written by mwood@beckershealthcare.com (Megan Wood)
- Category: Industry News
Here are four quick points: 1. The Aurora Spine Mobile App is designed to provide information on the company's products. 2. The company wanted to expand its reach, offering all product lines and surgical technique guides on a user's mobile device. 3. The app includes 3-D models as well as outlines features for every implant. 4. Users may access the app on Apple and Android devices. More articles on devices: Aurora Spine, Zimmer Biomet, DePuy Synthes & more: 11 key notes
- Written by Editor-in-Chief
- Category: Industry News
North America spinal implants market growing at CAGR 5.1% in the forecast period 2022 according to new research report Details WhaTech Channel: Medical Market Research Published: 06 December 2016 Submitted by Shubham DwivediWhaTech Pro News from Data Bridge Market Research Viewed: 0North America Spinal Implants Market, By Product Type (Fusion Implant Devices (Cervical Fusion (Anterior Cervical Fusion, Posterior Cervical Fusion), Thoraco-Lumbar Fusion (Anterior Thoraco-Lumbar Fusion, Posterior Thoraco-Lumbar Fusion, Interbody Thoraco-Lumbar Fusion)), Non-Fusion Implant Devices (Dynamic Stabilization Devices, Artificial Discs, Annulus Repair Devices, Nuclear Disc Prostheses), VCF Treatment Devices (Baloon Kyphoplasty Devices, Verteboplasty Devices)), By End-User (Hospitals, Spinal Surgery Centers, Orthopedic Clinics, Others), By Country (U.S.
- Written by Editor-in-Chief
- Category: Industry News
Jurors in Texas awarded six California plaintiffs $1.041 billion in a lawsuit against Johnson & Johnson and its subsidiary, DePuy Orthopaedic, over defective hip implants. It's another ignominious defeat for J&J, who've been hit with six of the seven largest jury awards this year, according to the American Bar Association. It's also another in a long line of lawsuit losses for J&J and DePuy over their hip implants, which plaintiffs allege cause tissue death, bone erosion, and other injuries. Not So Hip The most recent jury verdict, which concerns DePuy's Pinnacle hip implants, is comprised of $32 million in compensatory damages, and the rest in punitive damages.
- Written by Editor-in-Chief
- Category: Industry News
NEW YORK, Dec. 5, 2016 /PRNewswire/ -- Global biological implant market is anticipated to reach USD 9.8 billion by 2024, according to a new report by Grand View Research, Inc. Biological implant market is driven by rise in adoption of grafts and organ substitutes for reconstructive surgeries for various clinical applications such as cardiovascular, orthopedic and other soft tissue repair. The main challenge associated with the use of these products is to incorporate such a material that can specifically adapt to the biology of the surrounding environment in order to accelerate regeneration and repair. To overcome this challenge, research endeavors are carried out in order to develop such devices from biological source thus affecting industrial growth in the coming years.
Submit Community Content
If you have orthopedic information that you would like to share with the Orthogate Community, please register/login and submit your news, event, job, article, case or workshop from the Submit Content menu under the My Account area. Learn more!